{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:30:17Z","timestamp":1768480217347,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Research fund of Anhui Institute of Translational Medicine","award":["2021zhyx-C59"],"award-info":[{"award-number":["2021zhyx-C59"]}]},{"name":"Suzhou Science and Technology Key Project","award":["SZSKJJZC027"],"award-info":[{"award-number":["SZSKJJZC027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03698-9","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T11:02:23Z","timestamp":1727694143000},"page":"2191-2206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Construction of M2 macrophage-related gene signature for predicting prognosis and revealing different immunotherapy response in bladder cancer patients"],"prefix":"10.1007","volume":"27","author":[{"given":"Zhouting","family":"Tuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duobing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7399-1577","authenticated-orcid":false,"given":"Zhiwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7545-4240","authenticated-orcid":false,"given":"Jinyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"3698_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, et al. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Update. 2023;68: 100938. https:\/\/doi.org\/10.1016\/j.drup.2023.100938.","journal-title":"Drug Resist Update"},{"issue":"7","key":"3698_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s11255-020-02406-0","volume":"52","author":"D Feng","year":"2020","unstructured":"Feng D, Liu S, Tang Y, Yang Y, Wei W, Han P. Comparison of perioperative and oncologic outcomes between robot-assisted and laparoscopic radical cystectomy for bladder cancer: a systematic review and updated meta-analysis. Int Urol Nephrol. 2020;52(7):1243\u201354. https:\/\/doi.org\/10.1007\/s11255-020-02406-0.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3698_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupr\u00eat","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ, Capoun O, Comp\u00e9rat EM, Dominguez-Escrig JL, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol. 2023;84(1):49\u201364. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.013.","journal-title":"Eur Urol"},{"issue":"6","key":"3698_CR4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.14336\/AD.2023.0502","volume":"14","author":"D Feng","year":"2023","unstructured":"Feng D, Li D, Wu R, Han P. Scientific advancements in drug development and trials for urothelial carcinoma: insights from the 2023 ASCO-GU cancers symposium. Aging Dis. 2023;14(6):1953\u20137. https:\/\/doi.org\/10.14336\/AD.2023.0502.","journal-title":"Aging Dis"},{"issue":"7","key":"3698_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-023-00847-7","volume":"21","author":"CC Guo","year":"2024","unstructured":"Guo CC, Lee S, Lee JG, Chen H, Zaleski M, Choi W, et al. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat Rev Urol. 2024;21(7):391\u2013405. https:\/\/doi.org\/10.1038\/s41585-023-00847-7.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"3698_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40001-023-01012-x","volume":"28","author":"DX Li","year":"2023","unstructured":"Li DX, Feng DC, Wang XM, Wu RC, Zhu WZ, Chen K, et al. M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients. Eur J Med Res. 2023;28(1):55. https:\/\/doi.org\/10.1186\/s40001-023-01012-x.","journal-title":"Eur J Med Res"},{"key":"3698_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107302","volume":"206","author":"Z Tuo","year":"2024","unstructured":"Tuo Z, Zhang Y, Li D, Wang Y, Wu R, Wang J, et al. Relationship between clonal evolution and drug resistance in bladder cancer: a genomic research review. Pharmacol Res. 2024;206: 107302. https:\/\/doi.org\/10.1016\/j.phrs.2024.107302.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3698_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13073-020-00741-6","volume":"12","author":"HW Lee","year":"2020","unstructured":"Lee HW, Chung W, Lee HO, Jeong DE, Jo A, Lim JE, et al. Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Med. 2020;12(1):47. https:\/\/doi.org\/10.1186\/s13073-020-00741-6.","journal-title":"Genome Med"},{"issue":"2","key":"3698_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell. 2018;173(2):515\u201328. https:\/\/doi.org\/10.1016\/j.cell.2018.03.017.","journal-title":"Cell"},{"key":"3698_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216807","volume":"593","author":"H Lin","year":"2024","unstructured":"Lin H, Fu L, Zhou X, Yu A, Chen Y, Liao W, et al. LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer. Cancer Lett. 2024;593: 216807. https:\/\/doi.org\/10.1016\/j.canlet.2024.216807.","journal-title":"Cancer Lett"},{"issue":"1","key":"3698_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","volume":"16","author":"M Li","year":"2023","unstructured":"Li M, Yang Y, Xiong L, Jiang P, Wang J, Li C. Metabolism, metabolites, and macrophages in cancer. J Hematol Oncol. 2023;16(1):80. https:\/\/doi.org\/10.1186\/s13045-023-01478-6.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"3698_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.14336\/AD.2022.0407","volume":"13","author":"S Xing","year":"2022","unstructured":"Xing S, Hu K, Wang Y. Tumor immune microenvironment and immunotherapy in non-small cell lung cancer: update and new challenges. Aging Dis. 2022;13(6):1615\u201332. https:\/\/doi.org\/10.14336\/AD.2022.0407.","journal-title":"Aging Dis"},{"key":"3698_CR13","doi-asserted-by":"publisher","unstructured":"Huang A, Zhou W. Mn-based cGAS-STING activation for tumor therapy. Chin J Cancer Res. 2023;35(1):19-43. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2023.01.04","DOI":"10.21147\/j.issn.1000-9604.2023.01.04"},{"key":"3698_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100939","volume":"68","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang J, Hu X, Pan Z, Xu T, Xu J, et al. Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy. Drug Resist Update. 2023;68: 100939. https:\/\/doi.org\/10.1016\/j.drup.2023.100939.","journal-title":"Drug Resist Update"},{"issue":"1","key":"3698_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed A, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Tar. 2023;8(1):207. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","journal-title":"Signal Transduct Tar"},{"issue":"3","key":"3698_CR16","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.3892\/ol.2020.11814","volume":"20","author":"LA Wang","year":"2020","unstructured":"Wang LA, Yang B, Tang T, Yang Y, Zhang D, Xiao H, et al. Correlation of APE1 with VEGFA and CD163(+) macrophage infiltration in bladder cancer and their prognostic significance. Oncol Lett. 2020;20(3):2881\u20137. https:\/\/doi.org\/10.3892\/ol.2020.11814.","journal-title":"Oncol Lett"},{"issue":"1","key":"3698_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cas.12314","volume":"105","author":"Y Komohara","year":"2014","unstructured":"Komohara Y, Jinushi M, Takeya M. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci. 2014;105(1):1\u20138. https:\/\/doi.org\/10.1111\/cas.12314.","journal-title":"Cancer Sci"},{"key":"3698_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol. 2022;13: 888713. https:\/\/doi.org\/10.3389\/fimmu.2022.888713.","journal-title":"Front Immunol"},{"key":"3698_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310625","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zheng H, Gu AM, Li Y, Wang T, Li C, et al. Identification and validation of a metabolism-related prognostic signature associated with M2 macrophage infiltration in gastric cancer. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241310625.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3698_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12885-020-07734-z","volume":"21","author":"J Huo","year":"2021","unstructured":"Huo J, Wu L, Zang Y, Dong H, Liu X, He F, et al. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma. BMC Cancer. 2021;21(1):31. https:\/\/doi.org\/10.1186\/s12885-020-07734-z.","journal-title":"BMC Cancer"},{"key":"3698_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.609334","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yan K, Wang J, Lin J, Bi J. M2 macrophage co-expression factors correlate with immune phenotype and predict prognosis of bladder cancer. Front Oncol. 2021;11: 609334. https:\/\/doi.org\/10.3389\/fonc.2021.609334.","journal-title":"Front Oncol"},{"issue":"1","key":"3698_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12672-024-01008-x","volume":"15","author":"Z Tuo","year":"2024","unstructured":"Tuo Z, Lin Y, Zhang Y, Gao L, Yu D, Wang J, et al. Prognostic significance and immune landscape of a cell cycle progression-related risk model in bladder cancer. Discov Oncol. 2024;15(1):160. https:\/\/doi.org\/10.1007\/s12672-024-01008-x.","journal-title":"Discov Oncol"},{"key":"3698_CR23","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014; 507(7492):315\u2013322. https:\/\/doi.org\/10.1038\/nature12965.","DOI":"10.1038\/nature12965"},{"issue":"5","key":"3698_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-11-2271","volume":"18","author":"M Riester","year":"2012","unstructured":"Riester M, Taylor JM, Feifer A, Koppie T, Rosenberg JE, Downey RJ, et al. Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res. 2012;18(5):1323\u201333. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2271.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3698_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"key":"3698_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836939","volume":"13","author":"Q Xiong","year":"2022","unstructured":"Xiong Q, Feng D, Wang Z, Ying Y, Xu C, Wei Q, et al. Fatty acid synthase is the key regulator of fatty acid metabolism and is related to immunotherapy in bladder cancer. Front Immunol. 2022;13: 836939. https:\/\/doi.org\/10.3389\/fimmu.2022.836939.","journal-title":"Front Immunol"},{"issue":"5","key":"3698_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"issue":"21","key":"3698_CR28","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1093\/bioinformatics\/bti653","volume":"21","author":"Y Gao","year":"2005","unstructured":"Gao Y, Church G. Improving molecular cancer class discovery through sparse non-negative matrix factorization. Bioinformatics. 2005;21(21):3970\u20135. https:\/\/doi.org\/10.1093\/bioinformatics\/bti653.","journal-title":"Bioinformatics"},{"key":"3698_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092652","author":"AJ McEligot","year":"2020","unstructured":"McEligot AJ, Poynor V, Sharma R, Panangadan A. Logistic LASSO regression for dietary intakes and breast cancer. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12092652.","journal-title":"Nutrients"},{"issue":"11","key":"3698_CR30","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"issue":"1","key":"3698_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"issue":"10","key":"3698_CR32","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"issue":"7693","key":"3698_CR33","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138. https:\/\/doi.org\/10.1038\/nature25501.","journal-title":"Nature"},{"issue":"13","key":"3698_CR34","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/pmic.201100504","volume":"12","author":"A Asplund","year":"2012","unstructured":"Asplund A, Edqvist PH, Schwenk JM, Pont\u00e9n F. Antibodies for profiling the human proteome: the human protein atlas as a resource for cancer research. Proteomics. 2012;12(13):2067\u201377. https:\/\/doi.org\/10.1002\/pmic.201100504.","journal-title":"Proteomics"},{"issue":"1","key":"3698_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"WJ Alfred","year":"2024","unstructured":"Alfred WJ, Max BH, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85(1):17\u201331. https:\/\/doi.org\/10.1016\/j.eururo.2023.08.016.","journal-title":"Eur Urol"},{"issue":"5","key":"3698_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.23736\/S0393-2249.20.03829-1","volume":"72","author":"D Feng","year":"2020","unstructured":"Feng D, Tang Y, Yang Y, Han P, Wei W. Intracorporeal versus extracorporeal urinary diversion after robotic-assisted radical cystectomy: evidence from a systematic review and pooled analysis of observational studies. Minerva Urol Nefrol. 2020;72(5):519\u201330. https:\/\/doi.org\/10.23736\/S0393-2249.20.03829-1.","journal-title":"Minerva Urol Nefrol"},{"key":"3698_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010235","author":"A Abugomaa","year":"2020","unstructured":"Abugomaa A, Elbadawy M, Yamawaki H, Usui T, Sasaki K. Emerging roles of cancer stem cells in bladder cancer progression, tumorigenesis, and resistance to chemotherapy: a potential therapeutic target for bladder cancer. Cells-Basel. 2020. https:\/\/doi.org\/10.3390\/cells9010235.","journal-title":"Cells-Basel"},{"key":"3698_CR38","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.2147\/OTT.S267734","volume":"13","author":"X Wang","year":"2020","unstructured":"Wang X, Bai Y, Zhang F, Yang Y, Feng D, Li A, et al. Targeted inhibition of P4HB promotes cell sensitivity to gemcitabine in urothelial carcinoma of the bladder. Oncotargets Ther. 2020;13:9543\u201358. https:\/\/doi.org\/10.2147\/OTT.S267734.","journal-title":"Oncotargets Ther"},{"key":"3698_CR39","doi-asserted-by":"publisher","unstructured":"Cheng S, Li B, Yu J, Wang L. Update of latest data for combined therapy for esophageal cancer using  radiotherapy and immunotherapy: A focus on efficacy, safety, and biomarkers. Chin J Cancer Res. 2023;35(5):483-500. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2023.05.06.","DOI":"10.21147\/j.issn.1000-9604.2023.05.06"},{"issue":"3","key":"3698_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.urolonc.2022.12.005","volume":"41","author":"F Aljabery","year":"2023","unstructured":"Aljabery F, Shabo I, Saudi A, Holmbom M, Olson H, Jahnson S. The emerging role of cell cycle protein p53 expression by tumor cells and M2-macrophage infiltration in urinary bladder cancer. Urol Oncol-Semin Ori. 2023;41(3):148\u20139. https:\/\/doi.org\/10.1016\/j.urolonc.2022.12.005.","journal-title":"Urol Oncol-Semin Ori"},{"issue":"5","key":"3698_CR41","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.3892\/ol.2018.8173","volume":"15","author":"Z Xu","year":"2018","unstructured":"Xu Z, Wang L, Tian J, Man H, Li P, Shan B. High expression of B7\u2013H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder. Oncol Lett. 2018;15(5):6519\u201326. https:\/\/doi.org\/10.3892\/ol.2018.8173.","journal-title":"Oncol Lett"},{"issue":"4","key":"3698_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.urolonc.2017.11.020","volume":"36","author":"F Aljabery","year":"2018","unstructured":"Aljabery F, Olsson H, Gimm O, Jahnson S, Shabo I. M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer. Urol Oncol-Semin Ori. 2018;36(4):119\u201359. https:\/\/doi.org\/10.1016\/j.urolonc.2017.11.020.","journal-title":"Urol Oncol-Semin Ori"},{"issue":"4","key":"3698_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.urolonc.2013.10.012","volume":"32","author":"L Lima","year":"2014","unstructured":"Lima L, Oliveira D, Tavares A, Amaro T, Cruz R, Oliveira MJ, et al. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Urol Oncol-Semin Ori. 2014;32(4):449\u201357. https:\/\/doi.org\/10.1016\/j.urolonc.2013.10.012.","journal-title":"Urol Oncol-Semin Ori"},{"issue":"5","key":"3698_CR44","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.immuni.2024.03.021","volume":"57","author":"J Xiao","year":"2024","unstructured":"Xiao J, Wang S, Chen L, Ding X, Dang Y, Han M, et al. 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages. Immunity. 2024;57(5):1087\u2013104. https:\/\/doi.org\/10.1016\/j.immuni.2024.03.021.","journal-title":"Immunity"},{"issue":"3","key":"3698_CR45","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang H, Wei H, Wang H, Wang Z, Li J, Ou Y, et al. Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer. Cell Death Dis. 2022;13(3):206. https:\/\/doi.org\/10.1038\/s41419-022-04632-z.","journal-title":"Cell Death Dis"},{"issue":"10","key":"3698_CR46","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","volume":"19","author":"SM Pyonteck","year":"2013","unstructured":"Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19(10):1264\u201372. https:\/\/doi.org\/10.1038\/nm.3337.","journal-title":"Nat Med"},{"issue":"7","key":"3698_CR47","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1158\/1078-0432.CCR-12-2091","volume":"19","author":"E Eruslanov","year":"2013","unstructured":"Eruslanov E, Stoffs T, Kim WJ, Daurkin I, Gilbert SM, Su LM, et al. Expansion of CCR8(+) inflammatory myeloid cells in cancer patients with urothelial and renal carcinomas. Clin Cancer Res. 2013;19(7):1670\u201380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-2091.","journal-title":"Clin Cancer Res"},{"issue":"15","key":"3698_CR48","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1158\/1078-0432.CCR-20-4574","volume":"27","author":"L Wang","year":"2021","unstructured":"Wang L, Sfakianos JP, Beaumont KG, Akturk G, Horowitz A, Sebra RP, et al. Myeloid cell-associated resistance to PD-1\/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing. Clin Cancer Res. 2021;27(15):4287\u2013300. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4574.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"3698_CR49","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1158\/1078-0432.CCR-17-2687","volume":"24","author":"H Fu","year":"2018","unstructured":"Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Xie H, et al. Identification and validation of stromal immunotype predict survival and benefit from adjuvant chemotherapy in patients with muscle-invasive bladder cancer. Clin Cancer Res. 2018;24(13):3069\u201378. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2687.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"3698_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1046\/j.1442-2042.2000.00190.x","volume":"7","author":"T Hanada","year":"2000","unstructured":"Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N, Nomura Y. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol. 2000;7(7):263\u20139. https:\/\/doi.org\/10.1046\/j.1442-2042.2000.00190.x.","journal-title":"Int J Urol"},{"issue":"4","key":"3698_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","volume":"35","author":"L Cassetta","year":"2019","unstructured":"Cassetta L, Fragkogianni S, Sims AH, Swierczak A, Forrester LM, Zhang H, et al. Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets. Cancer Cell. 2019;35(4):588\u2013602. https:\/\/doi.org\/10.1016\/j.ccell.2019.02.009.","journal-title":"Cancer Cell"},{"key":"3698_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930352","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Qu X, Zhang M, Zhang L, Yang T, Ma M, et al. Identification of a six-gene prognostic signature for bladder cancer associated macrophage. Front Immunol. 2022;13: 930352. https:\/\/doi.org\/10.3389\/fimmu.2022.930352.","journal-title":"Front Immunol"},{"issue":"5","key":"3698_CR53","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.7150\/jca.49174","volume":"12","author":"X Ma","year":"2021","unstructured":"Ma X, Zhang Y, Wang S, Wei H, Yu J. Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: a systematic review. J Cancer. 2021;12(5):1318\u201333. https:\/\/doi.org\/10.7150\/jca.49174.","journal-title":"J Cancer"},{"issue":"1","key":"3698_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40779-023-00455-x","volume":"10","author":"GL Ma","year":"2023","unstructured":"Ma GL, Lin WF. Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy. Military Med Res. 2023;10(1):20. https:\/\/doi.org\/10.1186\/s40779-023-00455-x.","journal-title":"Military Med Res"},{"key":"3698_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683951","volume":"11","author":"Y Du","year":"2021","unstructured":"Du Y, Miao W, Jiang X, Cao J, Wang B, Wang Y, et al. The epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironmen remodeling, gene mutation, and ferroptosis. Front Oncol. 2021;11: 683951. https:\/\/doi.org\/10.3389\/fonc.2021.683951.","journal-title":"Front Oncol"},{"key":"3698_CR56","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2147\/OTT.S191321","volume":"12","author":"Z Wang","year":"2019","unstructured":"Wang Z, Zhou Q, Li A, Huang W, Cai Z, Chen W. Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer. Oncotargets Ther. 2019;12:1423\u201332. https:\/\/doi.org\/10.2147\/OTT.S191321.","journal-title":"Oncotargets Ther"},{"key":"3698_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.796743","volume":"8","author":"B Zhang","year":"2021","unstructured":"Zhang B, Xue Y, Zhao J, Jiang H, Zhu J, Yin H, et al. Shionone attenuates sepsis-induced acute kidney injury by regulating macrophage polarization via the ECM1\/STAT5 pathway. Front Med-Lausanne. 2021;8: 796743. https:\/\/doi.org\/10.3389\/fmed.2021.796743.","journal-title":"Front Med-Lausanne"},{"key":"3698_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103034","volume":"70","author":"W Xue","year":"2024","unstructured":"Xue W, Yu Y, Yao Y, Zhou L, Huang Y, Wang Y, et al. Breast cancer cells have an increased ferroptosis risk induced by system x(c)(-) blockade after deliberately downregulating CYTL1 to mediate malignancy. Redox Biol. 2024;70: 103034. https:\/\/doi.org\/10.1016\/j.redox.2024.103034.","journal-title":"Redox Biol"},{"issue":"1","key":"3698_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-021-00856-1","volume":"7","author":"W Xue","year":"2022","unstructured":"Xue W, Li X, Li W, Wang Y, Jiang C, Zhou L, et al. Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer. Signal Transduct Tar. 2022;7(1):35. https:\/\/doi.org\/10.1038\/s41392-021-00856-1.","journal-title":"Signal Transduct Tar"},{"issue":"9","key":"3698_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13913","volume":"51","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu C, Xie Y, Li X. Down-regulation of CYTL1 attenuates bleomycin-induced pulmonary fibrosis in mice by inhibiting M2 macrophage polarization via the TGF-\u03b2\/CCN2 axis. Clin Exp Pharmacol P. 2024;51(9): e13913. https:\/\/doi.org\/10.1111\/1440-1681.13913.","journal-title":"Clin Exp Pharmacol P"},{"key":"3698_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.927358","volume":"12","author":"J Si","year":"2022","unstructured":"Si J, Guo R, Xiu B, Chi W, Zhang Q, Hou J, et al. Stabilization of CCDC102B by loss of RACK1 through the CMA pathway promotes breast cancer metastasis via activation of the NF-\u03baB pathway. Front Oncol. 2022;12: 927358. https:\/\/doi.org\/10.3389\/fonc.2022.927358.","journal-title":"Front Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03698-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T06:03:20Z","timestamp":1745647400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03698-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["3698"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03698-9","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}